FibroGen (FGEN) Misses Q2 EPS by $1.79

FibroGen (NASDAQ: FGEN) reported Q2 EPS of ($1.88), $1.79 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.35 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Boeing lands two U.S. defense contracts worth over $711M
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results